NRX PharmaceuticalsNRXP

NRX Pharmaceuticals

NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. Stephen H. Willard

$43.6M

Market Cap • 28/03/2024

2017

(há 7 anos)
Fundação

2021

(3 years ago)
IPO

NASDAQ

Listagem
Flag of US

Wilmington

Sede • Delaware

Valuation

Valuation Indicators

Retorno Histórico

NRXPSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

0%

1 dia

25/03/2024

9%

1 semana

20/03/2024

80%

1 mês

27/02/2024

-27%

1 ano

27/03/2023

-95%

5 anos

28/03/2019

10 anos

Histórico